| Mrs Keisha R Church, CRNA | |
|
1200 Granada St, Accokeek, MD 20607-3026 | |
| (301) 203-6462 | |
| (301) 203-0317 |
| Full Name | Mrs Keisha R Church |
|---|---|
| Gender | Female |
| Speciality | Certified Registered Nurse Anesthetist (crna) |
| Experience | 15 Years |
| Location | 1200 Granada St, Accokeek, Maryland |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1679801419 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367500000X | Nurse Anesthetist, Certified Registered | R168546 (Maryland) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Virginia Hospital Center | Arlington, VA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Dominion Anesthesia Pllc | 7618863713 | 64 |
| Medstar Medical Group Anesthesiology Llc | 1052678034 | 456 |
News Archive
A risk-management program set up in 2012 by the U.S. Food and Drug Administration to curb improper prescribing of extended-release and long-acting opioids may not have been effective because of shortcomings in the program's design and execution, according to a paper from researchers at the Johns Hopkins Bloomberg School of Public Health.
Xeltis, a privately held medical device company dedicated to transforming standards of care in heart valve replacement and vascular surgery, has announced that it has finished enrollment in a five-patient feasibility study of implantable products intended to enable for the first time the spontaneous growth of natural, healthy heart valves and vessels. With its proprietary technology, the company has pioneered an entirely new therapeutic category called Endogenous Tissue Growth, or ETG, in which surgeons use unique implants designed to allow the body to repair itself by growing natural, healthy tissue.
The key to treating one of the most common types of human leukemia may lie within mutations in a gene called FLT3, according to new research led by physician-scientists at the University of California, San Francisco (UCSF) Helen Diller Family Comprehensive Cancer Center.
The use of electronic cigarettes, battery operated devices that often look like cigarettes and deliver vaporized nicotine, is on the rise, including among minors. In a survey between 2011 and 2012, 10 percent of high school students reported ever using an e-cigarette.
› Verified 8 days ago
| Entity Name | Dominion Anesthesia Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1073554952 PECOS PAC ID: 7618863713 Enrollment ID: O20040305000503 |
News Archive
A risk-management program set up in 2012 by the U.S. Food and Drug Administration to curb improper prescribing of extended-release and long-acting opioids may not have been effective because of shortcomings in the program's design and execution, according to a paper from researchers at the Johns Hopkins Bloomberg School of Public Health.
Xeltis, a privately held medical device company dedicated to transforming standards of care in heart valve replacement and vascular surgery, has announced that it has finished enrollment in a five-patient feasibility study of implantable products intended to enable for the first time the spontaneous growth of natural, healthy heart valves and vessels. With its proprietary technology, the company has pioneered an entirely new therapeutic category called Endogenous Tissue Growth, or ETG, in which surgeons use unique implants designed to allow the body to repair itself by growing natural, healthy tissue.
The key to treating one of the most common types of human leukemia may lie within mutations in a gene called FLT3, according to new research led by physician-scientists at the University of California, San Francisco (UCSF) Helen Diller Family Comprehensive Cancer Center.
The use of electronic cigarettes, battery operated devices that often look like cigarettes and deliver vaporized nicotine, is on the rise, including among minors. In a survey between 2011 and 2012, 10 percent of high school students reported ever using an e-cigarette.
› Verified 8 days ago
| Entity Name | Medstar Medical Group Anesthesiology Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1528578333 PECOS PAC ID: 1052678034 Enrollment ID: O20171129001837 |
News Archive
A risk-management program set up in 2012 by the U.S. Food and Drug Administration to curb improper prescribing of extended-release and long-acting opioids may not have been effective because of shortcomings in the program's design and execution, according to a paper from researchers at the Johns Hopkins Bloomberg School of Public Health.
Xeltis, a privately held medical device company dedicated to transforming standards of care in heart valve replacement and vascular surgery, has announced that it has finished enrollment in a five-patient feasibility study of implantable products intended to enable for the first time the spontaneous growth of natural, healthy heart valves and vessels. With its proprietary technology, the company has pioneered an entirely new therapeutic category called Endogenous Tissue Growth, or ETG, in which surgeons use unique implants designed to allow the body to repair itself by growing natural, healthy tissue.
The key to treating one of the most common types of human leukemia may lie within mutations in a gene called FLT3, according to new research led by physician-scientists at the University of California, San Francisco (UCSF) Helen Diller Family Comprehensive Cancer Center.
The use of electronic cigarettes, battery operated devices that often look like cigarettes and deliver vaporized nicotine, is on the rise, including among minors. In a survey between 2011 and 2012, 10 percent of high school students reported ever using an e-cigarette.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Keisha R Church, CRNA 1200 Granada St, Accokeek, MD 20607-3026 Ph: (301) 203-6462 | Mrs Keisha R Church, CRNA 1200 Granada St, Accokeek, MD 20607-3026 Ph: (301) 203-6462 |
News Archive
A risk-management program set up in 2012 by the U.S. Food and Drug Administration to curb improper prescribing of extended-release and long-acting opioids may not have been effective because of shortcomings in the program's design and execution, according to a paper from researchers at the Johns Hopkins Bloomberg School of Public Health.
Xeltis, a privately held medical device company dedicated to transforming standards of care in heart valve replacement and vascular surgery, has announced that it has finished enrollment in a five-patient feasibility study of implantable products intended to enable for the first time the spontaneous growth of natural, healthy heart valves and vessels. With its proprietary technology, the company has pioneered an entirely new therapeutic category called Endogenous Tissue Growth, or ETG, in which surgeons use unique implants designed to allow the body to repair itself by growing natural, healthy tissue.
The key to treating one of the most common types of human leukemia may lie within mutations in a gene called FLT3, according to new research led by physician-scientists at the University of California, San Francisco (UCSF) Helen Diller Family Comprehensive Cancer Center.
The use of electronic cigarettes, battery operated devices that often look like cigarettes and deliver vaporized nicotine, is on the rise, including among minors. In a survey between 2011 and 2012, 10 percent of high school students reported ever using an e-cigarette.
› Verified 8 days ago